JNJ-37822681

Brands containing JNJ-37822681, food notes, and the most important drug interactions.

BRANDS

No registered brands found for this active ingredient.

No food notes on record for this active ingredient.

first 10 of 25

BenzatropineMODERATE
The risk or severity of adverse effects can be increased when JNJ-37822681 is combined with Benzatropine.
Expert view
DeutetrabenazineMODERATE
The risk or severity of adverse effects can be increased when JNJ-37822681 is combined with Deutetrabenazine.
Expert view
TetrabenazineMODERATE
The risk or severity of adverse effects can be increased when JNJ-37822681 is combined with Tetrabenazine.
Expert view
ApomorphineMINOR
The therapeutic efficacy of Apomorphine can be decreased when used in combination with JNJ-37822681.
Expert view
AripiprazoleMINOR
The therapeutic efficacy of Aripiprazole can be decreased when used in combination with JNJ-37822681.
Expert view
BrexpiprazoleMINOR
The therapeutic efficacy of Brexpiprazole can be decreased when used in combination with JNJ-37822681.
Expert view
BromocriptineMINOR
The therapeutic efficacy of Bromocriptine can be decreased when used in combination with JNJ-37822681.
Expert view
CabergolineMINOR
The therapeutic efficacy of Cabergoline can be decreased when used in combination with JNJ-37822681.
Expert view
DihydroergocornineMINOR
The therapeutic efficacy of Dihydroergocornine can be decreased when used in combination with JNJ-37822681.
Expert view
DihydroergotamineMINOR
The therapeutic efficacy of Dihydroergotamine can be decreased when used in combination with JNJ-37822681.
Expert view